The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study-Reference-Cited by-同舟云学术

The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study

Published:2016-08-01 Issue:8 Volume:11 Page:e0158354
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Theil Gerit,Fischer Kersten,Weber Ekkehard,Medek Rita,Hoda Raschid,Lücke Klaus,Fornara Paolo

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Validation and clinical utility of prostate cancer biomarkers;HI Scher;Nat Rev Clin Oncol,2013

2. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer;JS De Bono;Clin Cancer Res,2008

3. Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience;D Olmos;Ann Oncol,2009

4. Challenges in the enumeration and phenotyping of CTC;FA Coumans;Clin Cancer Res,2012

5. Circulating tumor cells (CTC) detection: clinical impact and future directions;P Paterlini-Brechot;Cancer Lett,2007

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering the Biology of Circulating Tumor Cells through Single-Cell RNA Sequencing: Implications for Precision Medicine in Cancer;International Journal of Molecular Sciences;2023-08-02

2. Effect of pulsed laser parameters on photoacoustic flow cytometry efficiency in vitro and in vivo;Cytometry Part A;2023-07-29

3. Microfluidics engineering towards personalized oncology—a review;In vitro models;2023-07-13

4. A Parallelable 3D Microfluidic Chip for Circulating‐Tumor‐Cell Capture at Ultra‐High Throughput and Wide Flow Rate Range;Advanced NanoBiomed Research;2023-02-16

5. Circulating Tumor Cells in Men Treated for Prostate Cancer;Circulating Tumor Cells;2023